Clinical Trial

Japan FFRangio Clinical Outcomes Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2022 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study aims to collect data on clinical outcomes of real world patients undergoing FFRangio guided treatment for coronary artery disease in Japan and Israel through a retrospective multicentre registry.
Trial Details
NCT Number NCT05648396
Lead Sponsor Rabin Medical Center
Collaborators: Gifu Heart Center, Fukuoka Sanno Hospital, Saga-ken Medical Center Koseikan, Sakakibara Heart Institute, Fukuyama Cardiovascular Hospital, Ichinomiya-Nishi Hospital
Conditions Coronary Artery Disease
Enrollment 2,500 participants
Start Date 2022-11-07
Primary Completion 2024-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-12-13